Purchase Order 75N93024P00987
- Not listed
- This $20,850 firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 12, 2024. The contract is for RNA sequencing services to support NIAID's biomedical research efforts, with a completion date of September 11, 2025. Novogene is an experienced provider of genomic sequencing and bioinformatics services to various federal agencies, holding multiple prime contracts and...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $10,880 contract has a completion date of December 11, 2024 and was not set aside. Novogene is a provider of genomic sequencing and bioinformatics services, supporting various federal agencies' biomedical, agricultural, environmental, and basic research efforts. This award...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for RNA sequencing services. The $13,410.00 contract has a completion date of June 30, 2024. Novogene is a provider of next-generation sequencing technologies and has delivered sequencing and bioinformatics services to support biomedical research across various federal...
- This $9,950 firm fixed price purchase order was awarded by the Northeast Area division of a civilian federal agency to Novogene Corp Inc., a minority-owned small business specializing in genomic sequencing and bioinformatics services. The contract is for mRNA sequencing services, with a period of performance ending on September 30, 2018. Novogene has established itself as a key provider of DNA/RNA sequencing, library preparation, and data analysis services to various government agencies,...
- This is a $13,400 firm fixed-price purchase order contract awarded by the National Eye Institute, a civilian agency within the National Institutes of Health, to Novogene Corp Inc., a minority-owned small business. The contract is for cell handling and sequencing services, with a period of performance through September 30, 2024. Novogene is a genomics services provider that specializes in next-generation DNA and RNA sequencing, bioinformatics, and research support for federal agencies across...
- This is a firm fixed-price purchase order awarded by the Department of the Interior's Southeast Area to Novogene Corp Inc., a minority-owned small business. The $9,552.00 contract is for eukaryotic mRNA sequencing services, involving the preparation of 150 base pair paired-end libraries and the generation of 20 million raw reads per sample. The award does not have a set-aside designation. Novogene Corp Inc. is a provider of next-generation genomic sequencing and bioinformatics services,...
- This is a firm fixed-price purchase order awarded by the Northeast Area of the U.S. federal agency to Novogene Corp Inc., a minority-owned small business, for DNA sequencing services. The contract has a ceiling value of $84,050.00 and a performance period ending on April 30, 2018. Novogene is a provider of next-generation sequencing technologies, including whole genome, exome, transcriptome, and metagenomic sequencing, and has delivered services to various federal agencies such as the National...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Novogene Corporation Inc., a minority-owned small business based in Sacramento, California. The contract, valued at $14,925.00, is for human messenger RNA (mRNA) sequencing services. The contract has an ultimate completion date of December 4, 2020 and was awarded on June 26, 2019. Novogene is a provider of advanced genomic sequencing and bioinformatics services, and has secured multiple...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $24,577.00 firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for DNA and RNA sequencing services. This contract is set aside for small businesses. Novogene is a provider of next-generation sequencing technologies that has delivered services to support various federal agencies' biomedical, agricultural, environmental, and basic...
- This is a firm fixed-price purchase order contract awarded by the National Institute on Aging, a civilian federal agency, to Novogene Corporation Inc., a minority-owned small business based in Sacramento, California. The contract is for $21,800 and covers laboratory and testing services, specifically strand-specific mRNA sequencing and bioinformatics analysis, with a period of performance through March 31, 2026. Novogene has an established track record of providing advanced genomic sequencing...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Novogene Corp Inc., a minority-owned small business specializing in genomic sequencing and bioinformatics services. The $12,866.00 contract is for mRNA sequencing services to support NIAID's biomedical research efforts. Novogene has established itself as a key provider of DNA and RNA sequencing, library preparation, and data analysis services to various federal agencies, including previous awards from the National Institutes of Health, Department of Veterans Affairs, and U.S. Geological Survey. The company also holds a $120,000 Blanket Purchase Agreement with the U.S. Geological Survey for next-generation sequencing services to support its earth science research programs. This contract was awarded without a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 8/12/24 |